FIELD: medicine.
SUBSTANCE: invention refers to medicine and concerns using rhCC10 protein for preparing a therapeutic agent for the therapeutic or preventive effect on influenza virus.
EFFECT: invention provides reducing a pulmonary titre of influenza virus.
11 cl, 4 dwg, 1 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ATTENUATED INFLUENZA VECTORS FOR THE PREVENTION AND/OR TREATMENT OF INFECTIOUS DISEASES, AS WELL AS FOR CANCER TREATMENT | 2015 |
|
RU2628690C2 |
| PEPTIDE-BASED COMPOSITION SUPPRESSING REPLICATION OF INFLUENZA A VIRUS | 2018 |
|
RU2695336C1 |
| DIINDOLYLMETHANE DRUG PREPARATION AND USING IT FOR TREATING INFLUENZA AND RESPIRATORY VIRAL INFECTIONS | 2013 |
|
RU2537025C1 |
| SUBTYPE H1N1 INFLUENZA VIRUS STRAIN A/RUSSIA/OL/2009-MA FOR STUDY OF THERAPEUTIC AND PREVENTIVE ACTIVITY OF ANTIVIRAL PREPARATIONS in vitro AND in vivo | 2010 |
|
RU2451072C1 |
| ATTENUATED GRIPPOSE VECTOR AND MUCOSAL UNIVERSAL GRIPPOSE VACCINE ON ITS BASIS | 2016 |
|
RU2660562C2 |
| INTRODUCTION OF ERYTHORANE OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR ORTHOMYXOVIRAL INFECTIONS TREATMENT | 2013 |
|
RU2636622C2 |
| AGENT WITH ANTIVIRAL ACTIVITY AGAINST INFLUENZA A AND SARS-CoV-2 VIRUSES | 2022 |
|
RU2796748C1 |
| MUCOSAL INFLUENZA VIRUS VACCINE AND METHOD FOR INFLUENZA PREVENTION | 2004 |
|
RU2390351C2 |
| VACCINE COMPOSITION FOR USE IN IMMUNO-COMPROMISED POPULATIONS | 2013 |
|
RU2661408C2 |
| RECOMBINANT INFLUENZA VIRUS STRAINS EXPRESSING MYCOBACTERIAL PROTECTIVE ESAT-6 ANTIGEN AND USES THEREOF IN TUBERCULOSIS TREATMENT AND PROPHYLAXIS | 2005 |
|
RU2318872C2 |
